Erwin van Puijenbroek
- Co-authors
- Pablo UmañaSylvia HerterChristian KleinThomas FriessBirgit BossenmaierValeria NicoliniCarola H. RiesChristian A. Gerdes
- Topics
- Monoclonal and Polyclonal Antibodies Research (8 papers)Glycosylation and Glycoproteins Research (3 papers)CAR-T cell therapy research (3 papers)
- Partner nations
- SwitzerlandGermanyNetherlands
In The Last Decade
Erwin van Puijenbroek
10 papers receiving 215 citations
Peers
Comparison fields: 5 of 31
- Oncology 120
- Radiology, Nuclear Medicine and Imaging 118
- Immunology 97
- Molecular Biology 69
- Genetics 38
Countries citing papers authored by Erwin van Puijenbroek
This map shows the geographic impact of Erwin van Puijenbroek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erwin van Puijenbroek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erwin van Puijenbroek more than expected).
Fields of papers citing papers by Erwin van Puijenbroek
This network shows the impact of papers produced by Erwin van Puijenbroek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erwin van Puijenbroek. The network helps show where Erwin van Puijenbroek may publish in the future.
Co-authorship network of co-authors of Erwin van Puijenbroek
This figure shows the co-authorship network connecting the top 25 collaborators of Erwin van Puijenbroek. A scholar is included among the top collaborators of Erwin van Puijenbroek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erwin van Puijenbroek. Erwin van Puijenbroek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 9 | |
| 4 | 43 | |
| 5 | 44 | |
| 6 | 1 | |
| 7 | 8 | |
| 8 | 98 | |
| 9 | 7 | |
| 10 | Contribution of enhanced ADCC to superior in vivo efficacy of a novel type II humanized, third generation CD20 antibody (GA101) in NHL xenograft models | 2 |
| 11 | GA201, a novel humanized, glycoengineered EGFR antibody with enhanced ADCC and superior in vivo efficacy in xenograft models | 3 |
| 12 | 9 |
About Erwin van Puijenbroek
Erwin van Puijenbroek is a scholar working on Radiology, Nuclear Medicine and Imaging, Genetics and Oncology, having authored 12 papers that have together received 224 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (3 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (118 citations), Immunology (97 citations) and Oncology (120 citations). Erwin van Puijenbroek has collaborated with scholars based in Switzerland, Germany and Netherlands. Frequent co-authors include Pablo Umaña, Sylvia Herter, Christian Klein, Thomas Friess, Birgit Bossenmaier, Valeria Nicolini, Carola H. Ries, Christian A. Gerdes, Ekkehard Moessner and Sabine M. Lang. Their work appears in journals such as The Journal of Experimental Medicine, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.